A Study To Evaluate the Long-Term Safety, Tolerability and Effect on Disease Course (Q64661944)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Study To Evaluate the Long-Term Safety, Tolerability and Effect on Disease Course |
clinical trial |
Statements
A Multinational, Multicenter, Open-label, Single-assignment Extension of the MS-LAQ-301 (ALLEGRO) Study, to Evaluate the Long-term Safety, Tolerability and Effect on Disease Course of Daily Oral Laquinimod 0.6 mg in Subjects With Relapsing MS (English)
0 references
10 November 2009
0 references
1 July 2017
0 references
839
0 references
18 year
0 references
55 year
0 references